Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

BRAF Inhibition in Pediatric Ameloblastoma of the Jaw

2.

Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status

3.

Venetoclax Combo Shows Promise in Younger Patients With AML

4.

Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.

5.

Cancer care crowdfunding increasingly common, but rarely successful


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot